<DOC>
	<DOCNO>NCT00217204</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety PANCREASE MT ( pancrelipase microtablets ) improve steatorrhea ( excessive excretion fat feces ) infant toddler cystic fibrosis pancreatic insufficiency , ass whether consistency microtablets acceptable swallow infant toddler</brief_summary>
	<brief_title>An Effectiveness , Safety , Palatability Study Pancrelipase Microtablets Infants Toddlers With Cystic Fibrosis Fat Malabsorption</brief_title>
	<detailed_description>The objective randomized , Investigator-blinded , parallel group , multicenter , pilot study evaluate preliminary safety , palatability effectiveness pancrelipase microtablets improve fat absorption . The hypothesis PANCREASE MT provide effective , safe palatable pancreatic enzyme supplementation use treatment fat malabsorption cohort infant cystic fibrosis-related pancreatic insufficiency . On Day 1 study , parent instruct administer 500 unit lipase/kg/meal full five day . Stool collect analyze last 72 hour baseline period . On Day 6 study , subject randomly assign one four treatment group . Parents instructed administer appropriate dose full five day stool collect analyze last 72 hour randomize treatment period . Patients receive PANCREASE MT 500 unit lipase/kg/meal mouth maximum five dos per day first 120 hour . Patients receive PANCREASE MT 500 , 1000 , 1500 2000 unit lipase/kg/meal mouth , maximum five meal per day next 120 hour .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<mesh_term>Steatorrhea</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Diagnosis cystic fibrosis Excessive discharge fat feces Stable patient require pancreatic enzyme therapy No stable antibiotic therapy small bowel overgrowth No hypersensitivity pork product No use prokinetics eg , metoclopramide cisapride within last 30 day No nasogastric feed tube feed No use steroids No use concomitant H2 blocker proton pump inhibitor concomitant therapy</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>30 Months</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Cystic fibrosis</keyword>
	<keyword>Pancreatic insufficiency</keyword>
	<keyword>Steatorrhea</keyword>
	<keyword>Fat malabsorption</keyword>
	<keyword>Pancrelipase</keyword>
</DOC>